FDA approves booster shots for high-risk patients and people 65 and over
The approval also applied to people who work in healthcare or who work in jobs that put them at high risk.
The Facts Inside Our Reporter’s Notebook
The Food and Drug Administration on Wednesday evening approved Pfizer-BioNTech coronavirus booster shots for people considered high-risk of severe illness and those 65 and older.
The approval also allows booster shots for people ages 18 to 64 who work in the healthcare field, or whose job puts them at high risk for serious complications for the virus.
According to Axios, this approval comes just days after the FDA’s advisory board overwhelmingly rejected booster shots for widespread use among the public.
News, not Noise
- Former Buttigieg campaign adviser called Christine Blasey Ford 'Looney Tunes' in texts to team Cuomo
- Corporate backers of BLM undeterred by group's Christmas blitz against capitalism, holiday shopping
- MTG eyes legislation to force media to give same effort to correcting lies as to spreading them
- Wisconsin Elections Commission to face allegations of potentially illegal behavior
- Bill Clinton traveled with Ghislaine Maxwell, per Secret Service documents: Report